Thursday, January 17, 2013

Liver Diseases Therapeutics Market:MarketResearchReports.biz

This report covers the performance of the various drugs class
segment used in liver disease therapeutics in terms of their revenue.
The global market for liver diseases therapeutics is classified into
seven drug class segments namely, anti-viral drugs, vaccines,
immunosuppressants, immunoglobulins, targeted therapy, corticosteroids
and chemotherapy with their estimated and forecasted market size from
2012 to 2018, along with their compound annual growth rate.

This report also covers an in-depth competitive analysis for the
market, taking into consideration some of the major market players. The
market players considered are: Abbott Laboratories, Astellas Pharma Inc,
Gilead Science Inc., Merck & Co., Bristol-Myers Squibb, Novartis,
Pfizer and Roche. A detailed analysis of their business strategies,
company overview, financial overview, product portfolio and recent
developments is also provided in the report.

We have used secondary research for deriving our market numbers for
each segment of the research report and further validated our analysis
with C-level executives of major companies operating in liver diseases
therapeutics market through the means of primary research to finally
come up with our results. This research is specially designed to
estimate and analyze the performance of liver diseases therapeutics in a
global scenario. This research provides in-depth analysis of liver
diseases therapeutics market sales, trend analysis by segments.